Study of KCC Peptide Application in the Colon
NCT02156557
Colon Polyps, Colonic Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT Number: NCT02289053
Conflicting guideline recommendations for screening colonoscopy result due to scant data upon which to develop appropriate recommendations. No previous study has compared the prevalence of advanced adenomas or adenomas (any size) among 40-49 year old individuals with a first degree relative (FDR) with colorectal cancer (CRC) versus 40-49 year old average risk individuals with no family history of CRC. The purpose of this study is to determine the prevalence of colon adenomas in 40-49 year old individuals and identify risk factors associated with the presence of advanced adenomas. This data will provide evidence to determine appropriate colon cancer screening guidelines in 40-49 year old persons with a family history of colon polyps or colorectal cancer.
Looking for future studies?
Notify Me40 year–49 year
All sexes
Observational
Walter Reed National Military Medical Center, Bethesda, Maryland, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Data analysis will begin September 2014 for a duration of three months.
The outcome will be assessed after the completion of patient recruitment at all locations in August 2014. Advanced adenomas are defined as greater than or equal to 10 mm (1 cm). The presence of adenomas is determined be reviewing patient medical records and pathology reports.
Time frame: Data analysis will begin September 2014 for a duration of three months.
The outcome will be assessed after the completion of patient recruitment at all locations in August 2014. Advanced adenomas are defined as greater than or equal to 10 mm (1 cm). The presence of adenomas is determined be reviewing patient medical records and pathology reports.
Time frame: Data analysis will begin September 2014 for a duration of three months.
The outcome will be assessed after the completion of patient recruitment at all locations in August 2014. Advanced adenomas are defined as greater than or equal to 10 mm (1 cm). The presence of adenomas is determined be reviewing patient medical records and pathology reports.
Time frame: Data analysis will begin September 2014 for a duration of three months.
Logistic regression will be used to determine if specific risk factors are associated with the risk of adenomas in 40-49 year old individuals. Data will be collected from patient surveys and medical records.
University of Michigan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02156557
Colon Polyps, Colonic Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT00492193
Colon Polyps, Colonic Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT04369053
Adenoma, Colon Cancer
Birmingham, Alabama, United States
View Trial DetailsNCT03506321
Adenoma, Colon Polyp
Westmead, New South Wales, Australia
View Trial Details